Viewing Study NCT07412405


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-05-04 @ 2:28 PM
Study NCT ID: NCT07412405
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-17
First Post: 2025-12-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R
Sponsor: GUSTAVO SALGUERO
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult B-cell Acute Lymphoblastic Leukemia View
None Follicular Lymphoma (FL) View
None Mantle Cell Lymphoma (MCL) View
None Diffuse Large B-Cell Lymphoma (DLBCL) View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pilot View
None Implementation View
None Safety View
None ARI-0001 View
None CAR-T View
None CD19 View
None Lymphoma View
None Leukemia View
None Colombia View